Validating Wave 1 (2014) urinary cotinine and TNE-2 cut-points for differentiating Wave 4 (2017) cigarette use from non-use in the US using data from the PATH Study.
Kathryn C EdwardsAsia KhanEva SharmaLanqing WangJune FengBenjamin C BlountConnie S SosnoffDanielle M SmithMaciej Lukasz GoniewiczJennifer L PearsonAndrea C VillantiCristine D DelnevoMichelle T Bover ManderskiDorothy K HatsukamiRaymond S NiauraColm EverardHeather L KimmelKara DuffyBrian L RostronArseima Y Del Valle-PineroDana M van BemmelCassandra A StantonAndrew HylandPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Findings from can be used in clinical and epidemiological studies to reduce misclassification of cigarette smoking status.